Belongs to

• Center for Hematologic Malignancies

Types of Work

["2019"]

[[["Meeting Abstracts",1232],["Journal Articles",981],["Book Sections",63],["Reviews",51],["Editorials",29],["Research Letters",23],["Conference Papers",16],["Guidelines",15],["Correspondences",10],["Books Whole",4],["Miscellaneous",4]]]

[2428]

Popular keywords

• adult
• aged
• article
• cyclophosphamide
• doxorubicin
• female
• human
• humans
• male
• priority journal

Recent Works

1. Pirtobrutinib in covalent BTK inhibitor pre-treated mantle cell lymphoma: Updated results and subgroup analysis from the phase 1/2 BRUIN study with >3 years follow-up from start of enrollment

   Meeting Abstract

   Wang, M. L.; Shah, N. N.; Jurczak, W.; Zinzani, P. L.; Eyre, T. A.; Cheah, C. Y.; Ujjani, C. S.; Izutsu, K.; Ma, S.; Flinn, I.; more...
   Clinical Lymphoma, Myeloma and Leukemia (2023)

   Fulltext@MSK | Save
2. A multi-institutional prospective cohort study of minimal residual disease in peripheral T-cell lymphoma: Impact of autologous stem cell transplant (ASCT)

   Meeting Abstract

   Foley, N.; Russler-Germain, D.; Watkins, M.; Jacobsen, E.; Moskowitz, A.; Cashen, A.; Fehniger, T.; Kahl, B.; Bartlett, N.; Ghobadi, A.; more...
   Clinical Lymphoma, Myeloma and Leukemia (2023)

   Fulltext@MSK | Save
3. Mosunetuzumab monotherapy demonstrates durable efficacy with a manageable safety profile in patients with relapsed/refractory follicular lymphoma who received ≥2 prior therapies: Updated results from a pivotal phase II study

   Meeting Abstract

   Bartlett, N. L.; Sehn, L. H.; Matasar, M.; Schuster, S. J.; Assouline, S.; Giri, P.; Kuruvilla, J.; Canales, M.; Dietrich, S.; Fay, K.; more...
   Clinical Lymphoma, Myeloma and Leukemia (2023)

   Fulltext@MSK | Save